← Leaderboards
Richard Steven Matulewicz
Sloan-Kettering Inst Can Research
$776,496
Attributed
$776,496
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $194.1K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$776,496 · 1
By mechanism
K08$776,496 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Brett Stewart Carver$12,016,524
- James A Fagin$27,970,638
- Richard J Wong$6,099,844
- Babak J Mehrara$12,871,847
- Jesse Joshua Smith$3,709,431
Others in their field
Other Rising Stars on “Evidence Base”
- Rashada Alexander · American Association For The Advancement Of Science$22,676,040
- John Alam · Eip Pharma, Inc.$10,411,018
- Songthip T. Ounpraseuth · Univ Of Arkansas For Med Scis$10,363,762
- Sabrina Paganoni · Massachusetts General Hospital$9,819,674
- Suma Babu · Massachusetts General Hospital$9,819,674
- Jinsy Andrews · Columbia University Health Sciences$9,819,674
Research focus
Evidence BaseAdultActive LearningDrug PrescriptionsBiometryCancer DiagnosisCancer PatientCancer RecurrenceAcademic Medical CentersCare DeliveryCareer DevelopmentCaringClinicClinical Decision SupportClinic VisitsCollaborationsComorbidityComputerized Medical RecordCounselingCancer SurvivorData WarehouseDevelopment PlansDiagnosisEvidence Based Practice
Grant awards (4)
Optimizing Smoking Cessation Treatment for Patients with Bladder Cancer$194,124
K08 · FY2025 · CA · contact PI
Optimizing Smoking Cessation Treatment for Patients with Bladder Cancer$194,124
K08 · FY2024 · CA · contact PI
Optimizing Smoking Cessation Treatment for Patients with Bladder Cancer$194,124
K08 · FY2023 · CA · contact PI
Optimizing Smoking Cessation Treatment for Patients with Bladder Cancer$194,124
K08 · FY2022 · CA · contact PI